Matches in DBpedia 2014 for { ?s ?p Biovest International, Inc (OTCQB: BVTI) is a Tampa-based biotechnology company that is the majority-owned subsidiary of Accentia Biopharmaceuticals. Their flagship product candidate, BiovaxID, is a cancer vaccine whose first indication is intended to be indolent follicular Non-Hodgkin's Lymphoma.. }
Showing items 1 to 2 of
2
with 100 items per page.
- Biovest abstract "Biovest International, Inc (OTCQB: BVTI) is a Tampa-based biotechnology company that is the majority-owned subsidiary of Accentia Biopharmaceuticals. Their flagship product candidate, BiovaxID, is a cancer vaccine whose first indication is intended to be indolent follicular Non-Hodgkin's Lymphoma.".
- Biovest comment "Biovest International, Inc (OTCQB: BVTI) is a Tampa-based biotechnology company that is the majority-owned subsidiary of Accentia Biopharmaceuticals. Their flagship product candidate, BiovaxID, is a cancer vaccine whose first indication is intended to be indolent follicular Non-Hodgkin's Lymphoma.".